概述
Objective: To update for both clinicians and the lay public the evidence-based position statement published by
The North American Menopause Society (NAMS) in March 2007 regarding its recommendations for menopausal
hormone therapy (HT) for postmenopausal women, with consideration for the therapeutic benefit-risk ratio at
various times through menopause and beyond.